<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Regulatory Considerations for Microneedling Products; Guidance for Industry and Food and Drug Administration Staff; Availability</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <style>
        body { font-family: Arial, sans-serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { color: #333; }
        .metadata { color: #666; font-size: 0.9em; }
        .summary { margin-top: 20px; line-height: 1.5; }
        .source { margin-top: 20px; }
    </style>
</head>
<body>
    <h1>Regulatory Considerations for Microneedling Products; Guidance for Industry and Food and Drug Administration Staff; Availability</h1>
    <div class="metadata">Published: 2026-02-05 10:30:37</div>
    <div class="summary">The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance entitled "Regulatory Considerations for Microneedling Products." This guidance is being issued to assist industry in understanding when a microneedling product is a device as defined in the Federal Food, Drug, and Cosmetic Act (FD&C Act). This document also provides information on the regulatory pathway to market for microneedling devices for aesthetic use.</div>
    <div class="source">Source: <a href="https://www.federalregister.gov/documents/2020/11/10/2020-24943/regulatory-considerations-for-microneedling-products-guidance-for-industry-and-food-and-drug" target="_blank" rel="noopener noreferrer">https://www.federalregister.gov/documents/2020/11/10/2020-24943/regulatory-considerations-for-microneedling-products-guidance-for-industry-and-food-and-drug</a></div>
</body>
</html>
